Literature DB >> 18197892

Evidence for the regulation of L-type Ca2+ channels in the heart by reactive oxygen species: mechanism for mediating pathology.

Livia C Hool1.   

Abstract

1. It is well recognized that reactive oxygen species (ROS) can activate transduction pathways to mediate pathophysiology. An increase in ROS has been implicated in a number of cardiovascular disorders. Reactive oxygen species regulate cell function through redox modification of target proteins. One of these target proteins is the L-type Ca(2+) channel. 2. There is good evidence that thiol reducing and oxidizing compounds, including hydrogen peroxide, can influence calcium channel function. The evidence for regulation of the channel protein and regulatory proteins by thiol-specific modifying agents and relevance to hypoxia and oxidative stress is presented. 3. Clinical studies suggest that calcium channel antagonists may be beneficial in reducing myocardial injury associated with oxidative stress. The identification of cysteines as possible targets for intervention during hypoxic trigger of arrhythmia or chronic pathological remodelling is discussed.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18197892     DOI: 10.1111/j.1440-1681.2007.04727.x

Source DB:  PubMed          Journal:  Clin Exp Pharmacol Physiol        ISSN: 0305-1870            Impact factor:   2.557


  28 in total

1.  Superoxide enhances Ca2+ entry through L-type channels in the renal afferent arteriole.

Authors:  Paul A Vogel; Xi Yang; Nicholas G Moss; William J Arendshorst
Journal:  Hypertension       Date:  2015-06-01       Impact factor: 10.190

2.  Mitochondrial production of reactive oxygen species contributes to the β-adrenergic stimulation of mouse cardiomycytes.

Authors:  Daniel C Andersson; Jérémy Fauconnier; Takashi Yamada; Alain Lacampagne; Shi-Jin Zhang; Abram Katz; Håkan Westerblad
Journal:  J Physiol       Date:  2011-02-28       Impact factor: 5.182

3.  Arterial Smooth Muscle Mitochondria Amplify Hydrogen Peroxide Microdomains Functionally Coupled to L-Type Calcium Channels.

Authors:  Nathan L Chaplin; Madeline Nieves-Cintrón; Adriana M Fresquez; Manuel F Navedo; Gregory C Amberg
Journal:  Circ Res       Date:  2015-09-21       Impact factor: 17.367

4.  Predicted effects of nitric oxide and superoxide on the vasoactivity of the afferent arteriole.

Authors:  Anita T Layton; Aurélie Edwards
Journal:  Am J Physiol Renal Physiol       Date:  2015-07-15

5.  Mechanisms underlying the modulation of L-type Ca2+ channel by hydrogen peroxide in guinea pig ventricular myocytes.

Authors:  Lei Yang; Jianjun Xu; Etsuko Minobe; Lifeng Yu; Rui Feng; Asako Kameyama; Kazuto Yazawa; Masaki Kameyama
Journal:  J Physiol Sci       Date:  2013-07-10       Impact factor: 2.781

6.  Antioxidant defense and protection against cardiac arrhythmias: lessons from a mammalian hibernator (the woodchuck).

Authors:  Zhenghang Zhao; Raymond K Kudej; Hairuo Wen; Nadezhda Fefelova; Lin Yan; Dorothy E Vatner; Stephen F Vatner; Lai-Hua Xie
Journal:  FASEB J       Date:  2018-02-28       Impact factor: 5.191

Review 7.  Using iPSC Models to Probe Regulation of Cardiac Ion Channel Function.

Authors:  Arne A N Bruyneel; Wesley L McKeithan; Dries A M Feyen; Mark Mercola
Journal:  Curr Cardiol Rep       Date:  2018-05-25       Impact factor: 2.931

8.  Azelnidipine is a calcium blocker that attenuates liver fibrosis and may increase antioxidant defence.

Authors:  T Ohyama; K Sato; K Kishimoto; Y Yamazaki; N Horiguchi; T Ichikawa; S Kakizaki; H Takagi; T Izumi; M Mori
Journal:  Br J Pharmacol       Date:  2012-02       Impact factor: 8.739

9.  Cellular mechanisms underlying nitric oxide-induced vasodilation of descending vasa recta.

Authors:  Aurélie Edwards; Chunhua Cao; Thomas L Pallone
Journal:  Am J Physiol Renal Physiol       Date:  2010-11-17

10.  Free radical scavenger specifically prevents ischemic focal ventricular tachycardia.

Authors:  Dezhi Xing; Ashok K Chaudhary; Francis J Miller; James B Martins
Journal:  Heart Rhythm       Date:  2009-01-06       Impact factor: 6.343

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.